AMGN Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AMGN shares is 3551, representing 80.9% of the company's common stock.

UBS ASSET MANAGEMENT AMERICAS INC, in the last quarter, reduced its stake in AMGN by -7.03% restricting it's holding to 3.37 million shares of worth nearly $957.17M. LEGAL & GENERAL GROUP PLC also lessened -0.99% of the AMGN shares from its portfolio, reducing its holding to 4.97 million shares of worth $1.41B. BANK OF NEW YORK MELLON CORP also shunned AMGN shares holding by -2.43% last quarter which brought its holding to 5.36 million shares worth $1.52B.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in AMGN by 6.21% in the last quarter. The institutional holder raised its holding to 52.09 million shares having worth more than $14.81B. ENVESTNET ASSET MANAGEMENT INC also added 7.37% more shares of AMGN to its portfolio, raising its holding to 1.3 million shares of worth $370.09M. ALLIANZ ASSET MANAGEMENT GMBH also increased its AMGN shares holding by 5.76% which brought its holding to 1.35 million shares worth $383.78M.

The insider with the most stakes in AMGN is AMGEN INC , 10 percent owner at the company. Additionally, AMGN stock is highly held by Chairman, CEO and President Bradway Robert A and EVP, Research & Development Harper Sean E among others.

Company executives, directors, and other insiders own 0.21% percent of Amgen Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which AMGN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include GRYGIEL NANCY A., GRAHAM JONATHAN P, and GORDON MURDO.

There have been 0 transaction(s) during the past 6-months in which Amgen Inc. insiders have bought stock, totalling 0 shares

Around 0 Amgen Inc. shares are held by insiders, which represents about 0.21% of AMGN stock.

AMGN 10 percent owner, AMGEN INC holds the largest portfolio of the company's shares. AMGN shares owned by AMGEN total nearly 35.37 million.

UBS ASSET MANAGEMENT AMERICAS INC is the largest institutional owner in AMGN which holds 3.37 million shares worth $957.17M or 0.63% of the total AMGN shares outstanding followed by LEGAL & GENERAL GROUP PLC with ownership of 4.97 million shares representing 0.93% of the AMGN ownership. BANK OF NEW YORK MELLON CORP is the third largest stakeholder with 5.36 million shares or 1% of the ownership worth more than $1.52B.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AMGN is concerned, it is a stock which is optionable.

Number of AMGN shares short is 11.17M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 537.53M shares of AMGN are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AMGN has 536.04M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AMGN is 2.83.